Patents by Inventor Ana Marie LANDIN

Ana Marie LANDIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mesenchymal stem cells as vaccine adjuvants and methods for using the same
    Patent number: 11975068
    Abstract: The present invention provides a method of enhancing an immune response to a vaccine by administering a vaccine and a population of isolated allogeneic human mesenchymal stem cells. The present invention also provides kits comprising a vaccine in a first container and a population of isolated allogeneic human mesenchymal stem cells in a second container.
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: May 7, 2024
    Assignee: LONGEVERON, INC.
    Inventors: Joshua M. Hare, Ana Marie Landin
  • Methods of Using Human Mesenchymal Stem Cells to Effect Cellular and Humoral Immunity
    Publication number: 20190290698
    Abstract: The present invention provides a method of treating subjects with non-ischemic dilated cardiomyopathy by administering a therapeutically effective amount of an isolated population of allogeneic human mesenchymal stem cells. The present invention also provides a method of treating subjects with symptoms of aging frailty by administering a therapeutically effective amount of an isolated population of allogeneic human mesenchymal stem cells.
    Type: Application
    Filed: November 10, 2017
    Publication date: September 26, 2019
    Applicant: Longeveron LLC
    Inventors: Joshua M. Hare, Ana Marie Landin
  • MESENCHYMAL STEM CELLS AS VACCINE ADJUVANTS AND METHODS FOR USING THE SAME
    Publication number: 20190038742
    Abstract: The present invention provides a method of enhancing an immune response to a vaccine by administering a vaccine and a population of isolated allogeneic human mesenchymal stem cells. The present invention also provides kits comprising a vaccine in a first container and a population of isolated allogeneic human mesenchymal stem cells in a second container.
    Type: Application
    Filed: February 2, 2017
    Publication date: February 7, 2019
    Applicant: Longeveron LLC
    Inventors: Joshua M. HARE, Ana Marie LANDIN